Cost-utility analysis of an implantable cardioverterdefibrillator for the treatment of patients with ischemic or non-ischemic New York Heart Association class II or III heart failure in Colombia

INTRODUCTION: The use of an implantable cardioverter-defibrillator reduces the probability of sudden cardiac death in patients with heart failure. OBJECTIVE: To determine the cost-utility relationship of an implantable cardioverterdefibrillator compared to optimal pharmacological therapy for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Atehortúa, Sara, Senior, Juan Manuel, Castro, Paula, Ceballos, Mateo, Saldarriaga, Clara, Giraldo, Nelson, Mora, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2019
Materias:
Artículo Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357361/
https://www.ncbi.nlm.nih.gov/pubmed/31584764
http://dx.doi.org/10.7705/biomedica.4235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357361/
https://www.ncbi.nlm.nih.gov/pubmed/31584764
http://dx.doi.org/10.7705/biomedica.4235

Ejemplares similares